- Home
- TLSI vs PHH Comparison
TLSI vs PHH Comparison
Compare TLSI & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- PHH
- Stock Information
- Founded
- TLSI 2010
- PHH 2016
- Country
- TLSI United States
- PHH China
- Employees
- TLSI N/A
- PHH N/A
- Industry
- TLSI Medical Specialities
- PHH Package Goods/Cosmetics
- Sector
- TLSI Health Care
- PHH Consumer Discretionary
- Exchange
- TLSI Nasdaq
- PHH Nasdaq
- Market Cap
- TLSI 160.4M
- PHH 160.1M
- IPO Year
- TLSI N/A
- PHH 2024
- Fundamental
- Price
- TLSI $5.62
- PHH $12.79
- Analyst Decision
- TLSI Strong Buy
- PHH
- Analyst Count
- TLSI 6
- PHH 0
- Target Price
- TLSI $11.75
- PHH N/A
- AVG Volume (30 Days)
- TLSI 66.8K
- PHH 465.6K
- Earning Date
- TLSI 03-27-2025
- PHH 01-01-0001
- Dividend Yield
- TLSI N/A
- PHH N/A
- EPS Growth
- TLSI N/A
- PHH N/A
- EPS
- TLSI N/A
- PHH 0.02
- Revenue
- TLSI $29,431,000.00
- PHH $2,381,851.00
- Revenue This Year
- TLSI $55.43
- PHH N/A
- Revenue Next Year
- TLSI $50.09
- PHH N/A
- P/E Ratio
- TLSI N/A
- PHH $710.94
- Revenue Growth
- TLSI 58.99
- PHH N/A
- 52 Week Low
- TLSI $3.50
- PHH $3.70
- 52 Week High
- TLSI $10.42
- PHH $13.98
- Technical
- Relative Strength Index (RSI)
- TLSI 55.78
- PHH N/A
- Support Level
- TLSI $5.06
- PHH N/A
- Resistance Level
- TLSI $5.72
- PHH N/A
- Average True Range (ATR)
- TLSI 0.37
- PHH 0.00
- MACD
- TLSI 0.03
- PHH 0.00
- Stochastic Oscillator
- TLSI 90.65
- PHH 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.